Patents Represented by Attorney Stasia L. Ogden
  • Patent number: 6838285
    Abstract: Site-specific recombinase based methods for making a recombinant adenoviral genome, as well as kits for practicing the same and the recombinant adenovirus vectors produced thereby, are provided. In the subject methods, the subject genomes are prepared from donor and acceptor vectors that each include at least one site recombinase recognition site, where in certain preferred embodiments, one of the donor and acceptor vectors includes a single recombinase recognition site while the other includes two recombinase recognition sites. The acceptor vector includes an adenoviral genome having an E region deletion. The donor vector includes an insertion nucleic acid. In the subject methods, the donor and acceptor vectors are combined in the presence of a recombinase to produce an adenoviral genome that includes the insertion nucleic acid. The subject adenoviral genomes find use in a variety of applications, including as vectors for use in a variety of applications.
    Type: Grant
    Filed: September 17, 2002
    Date of Patent: January 4, 2005
    Assignee: Becton Dickinson
    Inventors: Andrew Alan Farmer, Thomas Patrick Quinn
  • Patent number: 5705366
    Abstract: Multiple target nucleic acids are amplified using polymerase chain reaction in the presence of a nonionic, polymeric volume exclusion agent. The amplification efficiency of low copy target nucleic acids is increased in the presence of the volume exclusion agent even though reduced primer levels are used. In this manner, amplification efficiency of a given target nucleic acid can be more readily manipulated.
    Type: Grant
    Filed: September 15, 1994
    Date of Patent: January 6, 1998
    Assignee: Johnson & Johnson Clinical Diagnostics, Inc.
    Inventor: John W. Backus